Ginetantum

Benzydamine

Method of action: Local Anesthetic, Stomatological

Treatment option: Bacterial Vaginosis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ginetantum

Property	Description
Active ingredient	Benzydamine Hydrochloride
Form	Oromucosal Solution or Spray
Pharmacological class	Local NSAID and Anesthetic
General purpose	Symptomatic relief of local pain and inflammation
Origin	Synthetic compound (Indazole derivative)

What is Ginetantum and What Type of Medicine Is It?

Ginetantum is a dedicated medicinal preparation whose active component is Benzydamine Hydrochloride, a synthetic compound (indazole derivative) developed exclusively for topical use. Pharmacologically, it is classified as a locally acting Non-Steroidal Anti-Inflammatory Drug (NSAID) that also possesses distinct local anesthetic properties. This dual classification establishes Ginetantum as an agent engineered to manage both localized pain and the underlying inflammation simultaneously. The substance is used for the management of localized discomfort and is a single-ingredient product.

Oromucosal Solution: Ginetantum's Specific Form and Application

Ginetantum is typically supplied in liquid forms, such as an oromucosal solution or spray, specifically designed for direct application to the moist lining of the mouth and throat. The route of administration is strictly topical/local, a characteristic differentiating it from systemic medications. The compound exhibits rapid localized activity and a preference for mucous membrane application. The solution format is optimized for rapid onset of relief, ensuring that the active ingredient coats the inflamed tissues efficiently to maximize its therapeutic effect exactly where the symptoms occur.

Core Purpose: How Ginetantum Provides Symptomatic Relief

The general purpose of Ginetantum is the symptomatic management of discomfort, soreness, and irritation within the oral and pharyngeal cavities, such as those arising from general throat irritation. Its core benefit is delivered through its twin actions: providing immediate alleviation of pain via its local anesthetic effect and reducing swelling through its anti-inflammatory activity. This focused mechanism ensures comfort for the patient by tackling both the pain sensation and the source of inflammation, offering relief without the generalized effects of orally ingested anti-inflammatory agents.

What side effects are possible with Ginetantum?

Possible Side Effects and Safety Information

The safety profile for Ginetantum (Benzydamine Hydrochloride) is organized by regulatory authorities to classify adverse reactions based on frequency, the specific body systems affected, and special safety constraints.

Frequency-Classified Adverse Reactions

The most frequently documented effects are local reactions at the application site, categorized according to official regulatory standards. These may include a stinging/burning sensation or oral numbness (hypoaesthesia), which are classified as uncommon (reported in ge1/1,000 to <1/100 patients).

More systemic adverse reactions are documented as being very rare (reported in <1/10,000 patients) and include skin reactions like pruritus or urticaria, or respiratory events such as laryngospasm or bronchospasm.

Serious Adverse Reactions and Safety Constraints

Official labels also detail serious, system-wide reactions, classified as frequency not known (cannot be estimated from available data). These potentially severe adverse effects involve the immune system (e.g., anaphylactic reaction, angioedema) and are monitored closely.

Safety constraints and precautions are specifically noted for certain individuals. Caution is advised for patients with a history of bronchial asthma, as the product may precipitate bronchospasm. Furthermore, due to the drug’s classification as an NSAID, use is not recommended for patients with known hypersensitivity to acetylsalicylic acid or other NSAIDs due to the risk of cross-sensitivity. Hypersensitivity to Benzydamine itself is a contraindication for use. The local stinging sensation is documented in regulatory sources to resolve upon continuation of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes the official overdose profile for Ginetantum (Macrogol-based laxative) as documented in government regulatory sources.

Overdose with this medicine primarily results in gastrointestinal effects, typically presenting as diarrhea. In cases of excessive or prolonged use, this can lead to severe fluid loss (dehydration) and subsequent electrolyte imbalances, specifically hypokalemia (low potassium) and hyponatremia (low sodium). Severe cases of hypokalemia may potentially result in cardiac or neuromuscular dysfunction.

Official Overdose Findings

Overdose Manifestation	Action / Outcome
Diarrhea / Abdominal Pain	Symptoms typically disappear with temporary interruption of treatment or dose reduction.
Fluid/Electrolyte Loss	Excessive loss requires medical correction of the imbalance (e.g., intravenous fluids).
Aspiration Risk	Neurologically impaired children administered large volumes via nasogastric tube are at particular risk.

When to Seek Immediate Medical Help

Immediate medical attention is required if you experience signs of a hypersensitivity reaction. These reactions are serious and may include sudden onset of rash, urticaria (hives), swelling, or anaphylactic shock. In such events, the medicine must be stopped immediately and a doctor consulted.

Patients with pre-existing conditions, such as heart failure, hepatic, or renal insufficiency, and the elderly should be monitored periodically as a precaution against the complications of overdose.

Therapeutic Uses of Ginetantum

What Ginetantum Treats: Main Uses and Benefits

Ginetantum is commonly used across conditions presenting with acute episodes of localized discomfort in the mouth and throat, such as pharyngitis, tonsillitis, and specific oral inflammations like stomatitis, gingivitis, and treatment-induced oral mucositis. This medication is applied in clinical settings that involve acute or unstable symptom patterns, particularly for relief after minor dental procedures or during post-tonsillectomy recovery.

It is used for managing symptom clusters that may become intense or disruptive, including intense pain, soreness, and swelling associated with these inflammatory states. The primary therapeutic benefit is that it contributes to improved day-to-day comfort by targeting pain and irritation from sensitive mucosal lesions, which assists with maintaining functional stability during symptomatic periods. It supports the patient during difficult episodes by easing distress and pain in the immediate application area.

Quick Fact: Relief for Localized Pain and Inflammation

Eligibility and Restrictions for Use

Ginetantum’s use is strictly governed by population-specific rules detailed in official regulatory prescribing information, defining who can and who must not use the medicine.

Populations Who Must Not Use Ginetantum

Use is absolutely contraindicated in patients with a known hypersensitivity or documented allergy to the active substance, Benzydamine Hydrochloride, or to any of the product’s excipients. This is the primary prohibition listed in regulatory documentation.

Age and Conditional Use Restrictions

Age Eligibility: Use is generally permitted for Adults and Adolescents (13 years and over). Use for children is allowed down to 6 years of age in most oromucosal formulations, but the medicine is not recommended for children under 6 years.
Conditional Caution: Caution is specifically advised for patients with a history of bronchial asthma due to a potential risk of bronchospasm. Conditional restrictions also apply to individuals with known sensitivity to acetylsalicylic acid or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and in cases of severe renal or hepatic impairment.

Pregnancy and Lactation Status

Regarding physiological status, use during Pregnancy should be avoided unless considered clearly necessary due to insufficient safety data. Similarly, use during Lactation (breastfeeding) is not recommended as excretion into human milk is generally unknown, necessitating regulatory caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Ginetantum, which contains the active ingredient Benzydamine Hydrochloride as a topical oromucosal solution, indicates a minimal risk of systemic interaction due to its localized administration and low systemic absorption.

Documented Interaction Profile

Category	Regulatory Documentation Statement
Drug-Drug Interactions	No known interactions with other medicinal products are documented. The localized action and minimal systemic exposure largely eliminate the potential for systemic pharmacokinetic or pharmacodynamic interactions.
Contraindicated Combinations	No specific drug combinations are formally listed as contraindicated due to an interaction mechanism in the official labeling.
Metabolic Interactions	None documented. The regulatory profile explicitly states "None known" regarding metabolic enzyme interactions (e.g., CYP-mediated).
Timing Requirements	No mandatory timing rules or separation requirements for co-administration with other medicines are listed.
Food/Alcohol/Herbal Products	No specific interactions with food or alcohol are documented. Official guidance notes that complementary medicines, herbal remedies, and supplements are not formally tested for their effect on this topical medicine.

Population-Specific Consideration

While not a co-administration interaction, the possibility of systemic action must be considered in patients with renal impairment. This is based on the absorption of Benzydamine from the oral mucosa and its subsequent excretion mostly unchanged through the urine, as noted in regulatory warnings.

Mechanism of Action

️ Mechanism of Action

Ginetantum's pharmacological activity involves three distinct, localized mechanistic domains. Its anti-inflammatory action results from the drug's capacity to interfere with intracellular signal transduction, specifically by inhibiting activity in the p38 Mitogen-Activated Protein Kinase (MAPK) pathway within local inflammatory cells. This interference suppresses the synthesis and subsequent release of crucial pro-inflammatory mediators like TNF-alpha and IL-1beta. The resulting modulation of the inflammatory cascade leads to altered local vascular permeability and tissue fluid accumulation.

Simultaneously, the drug acts on peripheral sensory nerve fibers. It engages mechanisms that stabilize the neuronal cell membrane, leading to the blockade of voltage-gated sodium channels ( Na^+ channels). This action prevents the generation and propagation of afferent nerve impulses, resulting in the physiological consequence of local nerve conduction blockade.

Additionally, the molecule's structural properties allow for integration into the membranes of susceptible microorganisms, causing physical destabilization and disruption of cell integrity, which leads to a reduction in viable local microorganism populations.

Dosage and Administration Information

General Principles of Administration

Ginetantum, which contains Benzydamine Hydrochloride, is strictly for topical/local use and is administered via the Oromucosal route (on the moist lining of the mouth and throat). The usage is symptom-dependent and not tied to meals. The medication is designed for short-term use only, and continuous, uninterrupted treatment must not exceed seven days unless a healthcare provider specifically directs otherwise.

Official Dosing and Frequency

Administration varies by the dosage form, which includes the oromucosal solution and spray:

Dosage Form	Standard Adult Dose	Frequency	Course Duration
Mouthwash (0.15% w/v)	15 mL per dose (rinse or gargle)	Every 1.5 to 3 hours as needed	7 days maximum
Spray (0.15% w/v)	4 to 8 puffs/sprays per dose	Every 1.5 to 3 hours as needed	7 days maximum

Procedural and Population Rules

For the solution, administration requires the user to expel the liquid after use; it must not be swallowed. Rinsing or gargling should be maintained for approximately 20 to 30 seconds. The mouthwash is typically used undiluted, though the solution may be diluted 1:1 with water if a stinging sensation occurs.

Regarding specific populations, no dose adjustment is required for older adults. Pediatric dosing is based on age and weight for the spray: children 6 to 12 years receive 4 sprays per dose, while children under 6 are dosed based on body weight, up to a 4-spray maximum. The 0.15% mouthwash is generally not recommended for those under 13 years of age.

Recent Clinical Evidence

Research Evidence for Acute Throat and Mouth Pain

The clinical evidence for Ginetantum (Benzydamine Hydrochloride) is built upon short-term, randomized, placebo-controlled trials used in research exploring how symptoms change over time in adult populations. Research for Ginetantum was studied for its use in conditions characterized by fluctuating manifestations, such as sore throat. Trials examined patient-reported outcomes describing perceived discomfort and difficulty swallowing, using standard scales. Findings describe patterns observed in the studies where measurements of discomfort were tracked, and symptomatic measurements varied between the active group and the control group over periods up to several days.

Research in Procedural and Specialized Care Settings

Ginetantum was evaluated in specific procedural settings, specifically focusing on postoperative sore throat associated with procedures requiring intubation. Systematic reviews studies monitored patient responses over defined time intervals, examining outcomes related to physical discomfort in the immediate recovery period. Research was also studied for its role in prevention related to radiation-induced oral mucositis (RIOM), evaluating the delay or prevention of severe inflammation during cancer therapy. The research highlights changes measured during the study period, with patterns showing the reported occurrence of severe inflammation varied between the preparation group and the control group.

Evidence Gaps and Areas of Uncertainty

Long-term effects are not fully established as follow-up durations were limited to the acute phase of the condition. Research studies explored Ginetantum mainly in adult populations; evidence for certain groups remains insufficient. Subgroup findings are uncertain or evidence is limited regarding its use in specific populations, such as children undergoing surgery or pregnant women. Furthermore, the comparative evidence is lacking in some contexts, meaning that while patterns are observed, certainty remains low when trying to understand the full picture of available symptom management options. The study results reflect the specific conditions and populations under which they were conducted.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Ginetantum (FAQ)

Q: Is Ginetantum available over-the-counter or do I need a prescription?

A: The regulatory classification of Ginetantum (Benzydamine Hydrochloride oromucosal solution/spray) can vary depending on your location. Official product information typically classifies this medicine as an Over-the-Counter (OTC) or Pharmacy-only product for temporary relief of localized symptoms. You can usually find it without a prescription, but its availability may be subject to pharmacy control in some regions.

Q: What should I do if I accidentally swallow a small amount of the mouthwash?

A: Accidental ingestion of a small amount is generally not associated with severe systemic issues according to official product information. However, if a large quantity is swallowed, systemic effects like dizziness, agitation, or stomach upset may occur. If a large quantity is swallowed, regulatory information advises contacting a healthcare professional or poison control center, as close monitoring and symptomatic care may be necessary.

Q: What are the common mistakes or errors people make when using the spray?

A: The official instructions for use emphasize certain safety precautions to ensure correct administration. These include ensuring the spray is not directed at the eyes and priming the pump by pressing it until a fine mist is produced before initial use. Following the detailed product instructions is recommended to deliver the medicine correctly to the intended area.

Q: Can I use this if I am pregnant or breastfeeding?

A: Official regulatory documents generally recommend avoiding the use of Ginetantum during pregnancy and while breastfeeding. This caution is due to insufficient safety data regarding the potential effects on the fetus or unknown excretion into human milk. Because of these limitations, consultation with a healthcare provider is generally advised prior to using the medicine if you are pregnant, planning to become pregnant, or are currently breastfeeding.

How should Ginetantum be stored and disposed of?

How to Store and Dispose of Ginetantum

The official labeling mandates specific rules for storing and discarding Ginetantum (Benzydamine Hydrochloride Oromucosal Spray) to maintain its stability and ensure safety.

Storage Requirements

Condition	Requirement
Temperature	Do not store above 25 C or 30 C (depending on the formulation).
Prohibitions	Do not refrigerate or freeze the solution.
Protection	Keep the medicine in the original package and outer carton to protect the contents.
Shelf-Life	Do not use past the expiry date or 6 months after the spray is first opened.
Safety	Keep this medicine out of the sight and reach of children.

Disposal Instructions

Expired or unused Ginetantum must not be thrown away with household trash or poured into wastewater. To dispose of the medicine properly and protect the environment, users are directed to ask a pharmacist how to correctly discard the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.